Dental management in palliative care of a patient with advanced oral cancer
A case report
DOI:
https://doi.org/10.5935/2525-5711.20210003Palavras-chave:
palliative care, tongue neoplasms, dental care for chronically illResumo
Tongue squamous cell carcinoma is one of the most prevalent and aggressive head and neck carcinomas. When diagnosed in an advanced stage is associated with a reduced overall survival rate due to the increased risk of locoregional recurrence and distant metastases. This article discusses the dental care strategies that were adopted regarding the progression to an incurable state of a 52-year-old man diagnosed with advanced tongue squamous cell carcinoma, which was initially treated with exclusive radiotherapy. In a 5-year-period, this patient developed severe lesions of osteoradionecrosis and also local tumor recurrence without the possibility of curative treatment. Palliative care in the dental context must be adopted in order to provide physical and emotional health still at the final moments in the patient’s life.
Referências
Warnakulasuriya S. Causes of oral cancer--an appraisal of controversies. Br Dent J. 2009 Nov;207(10):471-5.
Larsen SR, Johansen J, Sørensen JA, Krogdahl A. The prognostic significance of histological features in oral squamous cell carcinoma. J Oral Pathol Med. 2009 Sep;38(8):657-62.
Bernard WS, Christopher PW. World cancer report 2020. Geneva: World Health Organization (WHO); 2014.
Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009 Apr/May;45(4-5):309-16.
Thomson PJ. Perspectives on oral squamous cell carcinoma prevention-proliferation, position, progression and prediction. J Oral Pathol Med. 2018 Oct;47(9):803-7.
Mroueh R, Haapaniemi A, Saarto T, Grönholm L, Grénman R, Salo T, et al. Non-curative treatment of patients with oral tongue squamous-cell carcinoma. Eur Arch Otorhinolaryngol. 2019;276(7):2039-45.
World Health Organization (WHO). The solid facts - Palliative care. Geneva: WHO; 2004.
Silva EP, Sudigursky D. Concepções sobre cuidados paliativos: revisão bibliográfica. Acta Paul Enferm. 2008;21(3):504-8.
He Y, Liu Z, Tian Z, Dai T, Qiu W, Zhang Z. Retrospective analysis of osteoradionecrosis of the mandible: proposing a novel clinical classification and staging system. Int J Oral Maxillofac Surg. 2015 Dec;44(12):1547-57.
Bezerra NVF, Leite KLF, Medeiros MMD, Martins ML, Cardoso AMR, Alves PM, et al. Impact of the anatomical location, alcoholism and smoking on the prevalence of advanced oral cancer in Brazil. Med Oral Patol Oral Cir Bucal. 2018 May;23(3):e295-301.
Montoro JRMC, Hicz HA, Souza L, Livingstone D, Melo DH, Tiveron RC, et al. Fatores prognósticos no carcinoma espinocelular de cavidade oral. Rev Bras Otorrinolaringol. 2008 Nov/Dec;74(6):861-6.
Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, et al. Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw; 2020 Jul;18(7):873-98.
Schwartz DL, Hayes DN. The evolving role of radiotherapy for head and neck cancer. Hematol Oncol Clin North Am. 2020 feb;34(1):91-108.
Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg. 1983 May;41(5):283-8.
Nabil S, Samman N. Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. Int J Oral Maxillofac Surg. 2011 Mar;40(3):229-43.
Rice N, Polyzois I, Ekanayake K, Omer O, Stassen LFA. The management of osteoradionecrosis of the jaws - a review. Surgeon. 2015 Apr;13(2):101-9.
Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004 Nov;73(2):119-31.
Camolesi GC, Ortega KL, Medina JB, Campos L, Lorenzo-Pouso AI, Vila PG. Therapeutic alternatives in the management of osteoradionecrosis of the jaws. Systematic review. Med Oral Patol Oral Cir Bucal. 2021 Mar;26(2):e195-e207.
Mehra R, Cohen RB, Burtness BA. The role of cetuximab for the treatment of squamous cell carcinoma of the head and neck. Clin Adv Hematol Oncol. 2008 Oct;6(10):742-50.
Thompson JA, Schneider BJ, Brahmer J, Andrews S, Armand P, Bhatia S, et al. Management of immunotherapy-related toxicities, version 1.2019. J Natl Compr Canc Netw. 2019 Mar;17(3):255-89.
Chiodini I, Falchetti A, Merlotti D, Vainicher CE, Gennari L. Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis. Expert Rev Endocrinol Metab. 2020 Jul;15(4):283-98.
Macedo LFSL, Siqueira JM, Gonçales LMC, Gallo CB, Domaneschi C. Management of oral late sequelae in head and neck cancer long-term survivor awaiting re-irradiation: case report and literature review. J Oral Diag. 2020;5(1):e20200017.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 1969 Journal of Oral Diagnosis
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
